# Boston Scientific to acquire Devoro Medical for up to $336M

Boston Scientific announced an agreement to acquire Devoro Medical, developer of the WOLF Thrombectomy Platform, for an upfront payment of approximately $269 million for the 84% stake not yet owned, plus up to $67 million in milestones.

- Type: Acquisition
- Announced: 2021-09-21
- Where: United States
- Value: $336.0M
- Status: announced
- Products: WOLF Thrombectomy Platform, mechanical thrombectomy devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Devoro Medical](https://endata.com/companies/57850.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2021-09-21-Boston-Scientific-Announces-Agreement-to-Acquire-Devoro-Medical,-Inc), 2021-09-21: "Today, Boston Scientific Corporation (NYSE: BSX) announced an agreement to acquire Devoro Medical, Inc., developer of the WOLF Thrombectomy® Platform."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.